Why Sonoma Pharma (SNOA) Stock Skyrocketing On Thursday


20-Year Pro Trader Reveals His "MoneyLine"

Ditch your indicators and use the "MoneyLine." A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.


  • Sonoma Pharmaceuticals Inc (NASDAQ:SNOA) stock doubled in reaction to the launch of two new dental products
  • OroGenix Oral Hygiene Rinse is Sonoma's second dental product in the U.S. and was developed with its partner Gabriel Science LLC.
  • Additionally, Sonoma and its partner, Medical Systems Solutions, have launched Microdacyn Oral Care for professional and consumer use in Switzerland.
  • After launching Endocyn for root canal irrigation in December 2020, Sonoma's second dental product in the U.S. is an oral hygiene rinse. 
  • OroGenix Oral Hygiene Rinse uses Sonoma's patented Microcyn technology to cleanse teeth, gums, and mouth.
  • In Europe, Microdacyn60 Oral Care is intended to combat oral and pharyngeal infections and inflammation and reduce pain and coughing. 
  • Price Action: SNOA shares are up 123.10% at $12.47 during the market session on the last check Thursday.

20-Year Pro Trader Reveals His "MoneyLine"

Ditch your indicators and use the "MoneyLine." A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.


ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Posted In: Long IdeasNewsHealth CareMoversTrading IdeasGeneralBriefsDental